{"id":"doi:10.1016/j.addr.2022.114312","kind":"review","title":"Considerations for personalized neoantigen vaccination in Malignant glioma","authors":["Gavin P. Dunn","Ngima D. Sherpa","Jimmy Manyanga","Tanner Michael Johanns"],"author_count":4,"year":2022,"published":"2022-04-26","venue":"Advanced Drug Delivery Reviews","cited_by":51,"doi":"10.1016/j.addr.2022.114312","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1016/j.addr.2022.114312","archive_url":"https://space-kitty.com/papers/doi:10.1016/j.addr.2022.114312","updated":null,"pmid":"35487282","pmcid":null,"openalex_id":"W4224623377","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Glioma Diagnosis and Treatment"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"mrna-cancer-vaccines","name":"mRNA Therapeutics & Cancer Vaccines","domain_slug":"medicine"}],"cited_in_dossiers":[]}